These so-called HLA-DQ heterodimers enable the presentation of peptides that are derived from otherwise innocuous self- or non-self antigens (proteins from insulin producing beta cells in T1DM, gliadins in CD) and activate pathogenic effector T-cells [13]. Here, INS is linked to type 1 diabetes mellitus.